Skip to Main Content
Back to News

Lobbying Update: $30,000 of HARMONY BIOSCIENCES lobbying was just disclosed

None

$30,000 of HARMONY BIOSCIENCES lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Producing meeting materials; Assisting in meetings to secure support at federal level and awareness to policymakers."

You can find more data on corporate lobbying on Quiver Quantitative.

HRMY Insider Trading Activity

HRMY insiders have traded $HRMY stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $HRMY stock by insiders over the last 6 months:

  • FUND TRUST II MARSHMAN has traded it 2 times. They made 0 purchases and 2 sales, selling 4,600,000 shares.
  • IV PHARMA HOLDINGS, LLC VALOR has traded it 2 times. They made 0 purchases and 2 sales, selling 4,600,000 shares.
  • JEFFREY DIERKS (CHIEF COMMERCIAL OFFICER) has traded it 4 times. They made 0 purchases and 4 sales, selling 57,942 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HRMY Hedge Fund Activity

We have seen 104 institutional investors add shares of HRMY stock to their portfolio, and 108 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles